Montara Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Montara Therapeutics's estimated annual revenue is currently $3.4M per year.
- Montara Therapeutics's estimated revenue per employee is $155,000
- Montara Therapeutics's total funding is $28M.
Employee Data
- Montara Therapeutics has 22 Employees.
- Montara Therapeutics grew their employee count by 22% last year.
Montara Therapeutics's People
Name | Title | Email/Phone |
---|---|---|
1 | President & CEO | Reveal Email/Phone |
2 | VP Business Operations | Reveal Email/Phone |
3 | VP, Pharmacology | Reveal Email/Phone |
4 | VP, Discovery Chemistry | Reveal Email/Phone |
5 | VP Discovery/Biomarkers | Reveal Email/Phone |
6 | VP Business Operations | Reveal Email/Phone |
7 | Scientist | Reveal Email/Phone |
8 | Senior Scientist | Reveal Email/Phone |
9 | Senior Research Associate | Reveal Email/Phone |
Montara Therapeutics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Montara Therapeutics?
We are Montara Therapeutics, a San Francisco–based precision-medicine neuroscience biotech startup. Our team boasts significant experience from successful biotech firms such as Mitokinin, Denali, and Soteria, supported by a world-class Scientific Advisory Board (SAB).\n\nWe bring a new approach to tackling challenging established targets, along with unique experience in developing enzyme activators and domain expertise in mitophagy.\n\nOur mission is to create innovative therapies for diseases of the CNS, with a focus on precision medicine and genetically validated targets to enhance drug safety and efficacy.
keywords:N/A$28M
Total Funding
22
Number of Employees
$3.4M
Revenue (est)
22%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.1M | 22 | -15% | N/A |
#2 | $3.9M | 22 | -44% | N/A |
#3 | $1.6M | 22 | 5% | $13.6M |
#4 | $3.9M | 22 | -8% | N/A |
#5 | $1.4M | 22 | 0% | $4.7M |